Tue, Jul 29, 2014, 4:38 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Guided Therapeutics, Inc Message Board

  • usma1992 usma1992 May 15, 2013 6:46 AM Flag

    No splash...but the sales are beginning to show...

    Obviously, the benefit of being a small cap stock is that earnings are initially irrelevant. You aren't buying this stock for today... your buying it for the future and for the platform. The cash burn for this company is $400K a month or less. Obviously, the more machines in the field the less the burn because the high margin disposables are being used.

    The four questions I have that I really want the answer to are the following:
    1. Current metric for disposables used in Canadian machines... more or less than expected
    2. FDA timeline, if known
    3. Funding plan
    4. New Markets, current expected backlog...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The key issue is the funding and if they get FDA approval, whether that will allow them to secure some debt financing. Have they spoken about partnering in the US or do they plan on marketing themselves - I would guess building a marketing platform for the US would be extremely expensive upfront?

      • 1 Reply to tredleon
      • I would expect that building the "Home market" in the US will be a lot cheaper and easier to approach than going to build that export market through distributors ...
        Once the FDA approval received you'll see they'll switch their marketing priorities and in case we don't see a partnership or buy-out the marketing effort doesn't need to be massive and can still be build-up gradually.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.